Atlas Trials

Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer

Clinical trial NCT04931017 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04931017
Sponsor
Northwestern University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Carcinoma
Start date
2022-09-09
Primary completion
2026-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.